Evidence map›Paper›PMID 24297543›Full record

ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2014

Prediction of off-target drug effects through data fusion.

Emmanuel R Yera, Ann E Cleves, Ajay N Jain

Abstract read
In one paragraph

Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Extrapolative prediction using physically-based QSAR.Journal of computer-aided molecular design · 2016
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmanuel R YeraBioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Ann E Cleves
Ajay N Jain

Funding

Machine Learning in Chemistry and BiologyR01GM070481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2005 to 2013
$2.5M
Binding-Site Modeling with Multiple-Instance Machine-LearningR01GM101689 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2013 to 2020
$2.4M
NIGMS NIH HHS R01 GM070481NIGMS NIH HHS R01 GM101689
6 · The paper itself

Abstract

We present a probabilistic data fusion framework that combines multiple computational approaches for drawing relationships between drugs and targets. The approach has special relevance to identifying surprising unintended biological targets of drugs. Comparisons between molecules are made based on 2D topological structural considerations, based on 3D surface characteristics, and based on English descriptions of clinical effects. Similarity computations within each modality were transformed into probability scores. Given a new molecule along with a set of molecules sharing some biological effect, a single score based on comparison to the known set is produced, reflecting either 2D similarity, 3D similarity, clinical effects similarity or their combination. The methods were validated within acurated structural pharmacology database (SPDB) and further tested by blind application to data derived from the ChEMBL database. For prediction of off-target effects, 3D-similarity performed best as a single modality, but combining all methods produced performance gains. Striking examples of structurally surprising off-target predictions are presented.

Indexed as

Computational BiologyDatabases, PharmaceuticalData Interpretation, StatisticalDrug-Related Side Effects and Adverse ReactionsDrug RepositioningHumansModels, StatisticalMolecular ConformationMolecular Targeted TherapyPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID24297543
PMCPMC3897331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.